Orion Infusions (DHA:ORIONINFU) Change In Receivables : BDT43.5 Mil (TTM As of Mar. 2024)

View and export this data going back to . Start your Free Trial

What is Orion Infusions Change In Receivables?

Orion Infusions's change in receivables for the quarter that ended in Mar. 2024 was BDT32.9 Mil. It means Orion Infusions's Accounts Receivable declined by BDT32.9 Mil from Dec. 2023 to Mar. 2024 .

Orion Infusions's change in receivables for the fiscal year that ended in Jun. 2023 was BDT16.5 Mil. It means Orion Infusions's Accounts Receivable declined by BDT16.5 Mil from Jun. 2022 to Jun. 2023 .

Orion Infusions's Accounts Receivable for the quarter that ended in Mar. 2024 was BDT102.2 Mil.

Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed. Orion Infusions's Days Sales Outstanding for the three months ended in Mar. 2024 was 44.65.

In Ben Graham's calculation of liquidation value, Apple Inc's Accounts Receivable are only considered to be worth 75% of book value. Orion Infusions's liquidation value for the three months ended in Mar. 2024 was BDT-334.3 Mil.

Orion Infusions Change In Receivables Historical Data

The historical data trend for Orion Infusions's Change In Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Orion Infusions Change In Receivables Chart

Orion Infusions Annual Data

Trend

Jun14

Jun15

Jun16

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

Change In Receivables

Get a 7-Day Free Trial

-8.09

-7.34

16.48

Orion Infusions Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Change In Receivables	Get a 7-Day Free Trial															4.64	13.90	-4.19	0.87	32.95

Orion Infusions Change In Receivables Calculation

Change In Accounts Receivable relative to the previous period. It is any increase or decrease in the cash a company is owed by its customers.

Change In Receivables for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was BDT43.5 Mil.

Orion Infusions (DHA:ORIONINFU) Change In Receivables Explanation

1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Orion Infusions's Days Sales Outstanding for the quarter that ended in Mar. 2024 is calculated as:

	Days Sales Outstanding
=	Accounts Receivable	/	Revenue	*	Days in Period
=	102.235	/	208.926	*	91
=	44.65

2. In Ben Graham's calculation of liquidation value, Orion Infusions's accounts receivable are only considered to be worth 75% of book value:

Orion Infusions's liquidation value for the quarter that ended in Mar. 2024 is calculated as:

	Liquidation Value
=	Cash, Cash Equivalents, Marketable Securities	-	Total Liabilities	+	(0.75 * Accounts Receivable)	+	(0.5 * Total Inventories)
=	19.243	-	492.294	+	0.75 * 102.235	+	0.5 * 124.125
=	-334.3

Orion Infusions Change In Receivables Related Terms

Thank you for viewing the detailed overview of Orion Infusions's Change In Receivables provided by GuruFocus.com. Please click on the following links to see related term pages.

Orion Infusions (DHA:ORIONINFU) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Orion Infusions Ltd (DHA:ORIONINFU) » Definitions » Change In Receivables

Comparable Companies

Traded in Other Exchanges

N/A

Address

Tejgaon Industrial Area, No. 153-154, Dhaka, BGD, 1208

Website

https://www.orioninfusion.com

Orion Infusions Ltd is a pharmaceutical company. It produces various types of intravenous fluids, rehydration solutions, electrolyte solutions, antimicrobial products, and other pharmaceutical products in Bangladesh. The products of the company include Dextrolac, Dextropac, Dextrosal, Dianak, Electro dex, fructose, Hartman, Intralipid, Manisol, Maprocin, Nidazyl, Orlev, Ortac, Plasmasol, Proliv, and Salpac. In addition, the company is also involved in activities related to cosmetics and toiletries, infrastructure development, real estate and construction, power, agro products, hospitality, textiles and garments, and aviation management sectors. Geographically, it operates in Bangladesh.

Orion Infusions (DHA:ORIONINFU) Headlines

No Headlines